Bliss GVS Pharma (BOM:506197) Moat Score: 0/10 (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506197 Bliss GVS Pharma Ltd BOM:506197
57 GF Score
Price ₹458.05
GF Value ₹152.18
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Bliss GVS Pharma Moat Score?

Bliss GVS Pharma has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Bliss GVS Pharma has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Bliss GVS Pharma might have No Moat - No discernible moat.

Bliss GVS Pharma  (BOM:506197) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Bliss GVS Pharma Moat Score Related Terms

BOM:506197
57GF Score
Bliss GVS Pharma Ltd BOM:506197
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bliss GVS Pharma (BOM:506197) Overvalued in 2026?

Based on GuruFocus' analysis, Bliss GVS Pharma stock appears to be overvalued. The current stock price of ₹458.05 is trading 201% above its estimated GF Value™ of ₹152.18. GuruFocus considers Bliss GVS Pharma to be Significantly Overvalued.

Key valuation signals for BOM:506197:

  • Moat Score: 0
  • GF Value™: ₹152.18 vs. price of ₹458.05 (201% above fair value)
  • GF Score™: 57/100 with 1 warning sign

No single metric tells the full story. See the BOM:506197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bliss GVS Pharma Business Description

Other Exchanges BLISSGVS:India
Address Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.
57GF Score

Get the complete analysis for BOM:506197

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹458.05
Price
₹152.18
GF Value